Li, J., Liu, W., Hao, H., Wang, Q., & Xue, L. (2019). Rapamycin enhanced the antitumor effects of doxorubicin in myelogenous leukemia K562 cells by downregulating the mTOR/p70S6K pathway. Oncol Lett.
Styl ChicagoLi, Jie, Wenjing Liu, Hongling Hao, Qiuyi Wang, a Liying Xue. "Rapamycin Enhanced the Antitumor Effects of Doxorubicin in Myelogenous Leukemia K562 Cells By Downregulating the MTOR/p70S6K Pathway." Oncol Lett 2019.
Citace podle MLALi, Jie, et al. "Rapamycin Enhanced the Antitumor Effects of Doxorubicin in Myelogenous Leukemia K562 Cells By Downregulating the MTOR/p70S6K Pathway." Oncol Lett 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..